Amgen has attracted about $56 billion in demand for a mega bond deal. Amgen sees about $55.7 billion of investor orders on Wednesday for its mega bond deal, signaling strong demand for financing tied to its $28 billion purchase of Horizon Therapeutics. (MarketWatch)
GSK was warned about the cancer risks of Zantac decades ago. The British pharma giant said the heartburn drug doesn’t cause tumors, but the company was warned by its own scientists and independent researchers about the potential danger. (Bloomberg)
Bausch + Lomb named Brent Saunders as its CEO. Saunders will succeed Joseph Papa, who had said last July that he would step down from his roles running the company and serving on its board. (The Wall Street Journal)
The New Yorker published a column outlining the policy objectives of Sen. Bernie Sanders, (I-VT), as he helms the Senate Committee on Health, Education, Labor, and Pensions. “So we have to pick on the incredible greed of the pharmaceutical industry, who make huge profits every year and pay their C.E.O.s huge salaries and compensation packages,” he said. “That’s something we are going to go into big time.” (The New Yorker)
Cameroon identified suspected cases of Marburg virus. Equatorial Guinea officially declared its first outbreak of the Marburg virus, an illness similar to Ebola, on Monday. (CNN)
